2026 Prescription Guide
Dartmouth Health Weight Center
Enter
Click me for Instructions
Common Medications
Please click the name of the medication you would like to learn more about
Contrave
Wegovy
Qsymia
Saxenda
Zepbound
Trulicity
Metformin
Mounjaro
Ozempic
Victoza
If there is a medication you are currently prescribed by your provider, or are interested in taking that is not listed here, please get in touch with your Weight Center provider for more information
References
OZEMPIC
oh-ZEM-pick
Semaglutide sem-a-GLOO-tide
Uses: Type 2 diabetes management and certain cardiovascular or kidney-related uses
Administration Method: Subcutaneous injection
Common Side Effects: Nausea, vomiting, diarrhea, abdominal pain, and constipation
Interactions: Insulin or sulfonylureas may increase hypoglycemia risk; oral medicines may absorb differently with delayed gastric emptying; warfarin may need monitoring; caution with dehydration-producing medications
Medication may vary due to dosage and adminstration method
CAUTION: use caution with previous history of pancreatitis, diabetic retinopathy, gastroparesis, and procedures requiring anesthesia. Do not use if you have MEN 2 or if you or a family member have had thyroid cancer.
Injection Training
Dosage: 0.25 mg, 0.5 mg, 1 mg, 2 mg
Please note that this is a general guide and not an extended list of all information available on this medication. For specifics on injection training, or questions, please contact your provider.
Wegovy
we-GOH-vee
Semaglutide sem-a-GLOO-tide
Uses: Chronic weight management in eligible patients as part of reduced-calorie diet and increased physical activity
Administration Method: Subcutaneous injection , oral tablet
Common Side Effects: Nausea, vomiting, diarrhea, abdominal pain, and constipation
Interactions: Insulin or sulfonylureas may increase hypoglycemia risk; oral medicines may absorb differently with delayed gastric emptying; warfarin may need monitoring
CAUTION: Do not use if you have MEN 2 or if you or a family member have had thyroid cancer. report severe abdominal pain, vision changes, persistent vomiting, or thyroid tumor symptoms.
Medication may vary due to dosage and adminstration method
Injection Training
Dosage: 0.25 mg - 7.2 mg for auto injector; 1.25 mg, 4 mg, 9 mg, 25 mg oral tablet
Please note that this is a general guide and not an extended list of all information available on this medication. For specifics on injection training, or questions, please contact your provider.
Victoza
vik-TOE-za
Liraglutide Lir-a-GLOO-tide
Uses: Type 2 diabetes management and cardiovascular risk reduction in certain patients
Administration Method: Subcutaneous injection
Common Side Effects: Nausea, vomiting, diarrhea, decreased appetite, abdominal discomfort
Interactions: Insulin or sulfonylureas may increase hypoglycemia risk; oral medicines may absorb differently with delayed gastric emptying; warfarin may need monitoring.
Medication may vary due to dosage and adminstration method
CAUTION: use caution with pancreatitis history and dehydration. Do not take if you have MEN 2, or if you or a family member have had thyroid cancer.
Injection Training
Dosage: 0.6 mg, 1.2 mg, 1.8 mg
Please note that this is a general guide and not an extended list of all information available on this medication. For specifics on injection training, or questions, please contact your provider.
Zepbound
ZEP-bound
Tirzepatide tir-ZEP-a-tide
Uses: Chronic weight management and obstructive sleep apnea indication in eligible adults
Administration Method: Subcutaneous injection
Common Side Effects: Nausea, vomiting, diarrhea, constipation, abdominal pain
Interactions: Insulin or sulfonylureas may increase hypoglycemia risk; oral medicines may absorb differently with delayed gastric emptying; warfarin may need monitoring.
Medication may vary due to dosage and adminstration method
CAUTION: use caution with history of pancreatitis, dehydration, avoid use in pregnancy, monitor for mood changes. Do not take if you have MEN2, or if your or a family member have had thyroid cancer.
Pen Injection Training
Vial Injection Training
Dosage: 2.5 mg, 5 mg, 7.5 mg, 10 mg
Please note that this is a general guide and not an extended list of all information available on this medication. For specifics on injection training, or questions, please contact your provider.
Qsymia
kyoo-SIM-ee-uh
Phentermine and Topiramate
Uses: Chronic weight management in appropriate patients with obesity or overweight plus weight-related conditions
Administration Method: Oral extended-release capsule
Common Side Effects: Dry mouth, constipation, insomnia, tingling, dizziness
Interactions: MAO inhibitors; other stimulants; carbonic anhydrase inhibitors; CNS depressants; non-potassium-sparing diuretics
CAUTION: use caution with glaucoma, hyperthyroidism, and recent MAOI use; monitor heart rate, mood changes, and potassium. Do not take if you are pregnant or breast feeding.
Medication may vary due to dosage and adminstration method
Please note that this is a general guide and not an extended list of all information available on this medication. For specifics, or questions, please contact your provider.
Dosage: Specific dosages vary, starting dose is 3.75 mg Phentermine / 23 mg Topiramate once daily.
Metformin
met-FOR-min
Biguanide
Uses: Type 2 diabetes treatment; also widely used in related insulin-resistance settings
Administration Method: Oral tablet, extended-release tablet, oral solution
Common Side Effects: Diarrhea, nausea, abdominal upset, metallic taste
Interactions: Iodinated contrast exposure; alcohol excess; cationic drugs affecting renal clearance; carbonic anhydrase inhibitors; other glucose-lowering drugs may increase hypoglycemia when combined
Medication may vary due to dosage and adminstration method
CAUTION: Take with food to reduce stomach upset; report severe weakness, breathing trouble, or muscle pain; alert your provider of liver impairment. Do not take if you have severe renal dysfunction, or are at risk for lactic acidosis.
Please note that this is a general guide and not an extended list of all information available on this medication. For specifics, or questions, please contact your provider.
Dosage: 500 mg - 1000 mg
Contrave
CON-trayv
opioid antagonist plus aminoketone antidepressant
Uses: Chronic weight management in appropriate adults with obesity or overweight plus weight-related conditions
Administration Method: Oral extended-release tablet
Common Side Effects: Nausea, constipation, headache, dry mouth, insomnia
Interactions: Opioids; MAO inhibitors; other bupropion-containing products; alcohol misuse; medicines that lower seizure threshold
Medication may vary due to dosage and adminstration method
CAUTION: Contraindicated in seizure disorder, anorexia or bulimia, uncontrolled hypertension, chronic opioid use, abrupt withdrawal from alcohol or sedatives, and MAOI use; monitor for suicidality and blood pressure increases. Follow the titration schedule carefully; do not take extra tablets; avoid opioid pain medicines while using it
Please note that this is a general guide and not an extended list of all information available on this medication. For specifics, or questions, please contact your provider.
Dosage: Naltrexone 8mg / Bupropion 90 mg (Most Common)
Mounjaro
moun-JAR-oh
Tirzepatide tir-ZEP-a-tide
Uses: Type 2 diabetes management
Administration Method: Subcutaneous injection
Common Side Effects: Nausea, vomiting, diarrhea, constipation, abdominal pain
Interactions: Insulin or sulfonylureas may increase hypoglycemia risk; oral medicines may absorb differently with delayed gastric emptying; warfarin may need monitoring.
Medication may vary due to dosage and adminstration method
CAUTION: use caution with history of pancreatitis, dehydration, avoid use in pregnancy, monitor for mood changes. Do not take if you have MEN2, or if your or a family member have had thyroid cancer.
Pen Injection Training
Vial Injection Training
Dosage: 2.5 mg once weekly up to a maximum of 15 mg once weekly
Please note that this is a general guide and not an extended list of all information available on this medication. For specifics on injection training, or questions, please contact your provider.
Saxenda
sax-EN-da
Liraglutide Lir-a-GLOO-tide
Uses: Chronic weight management with reduced-calorie diet and increased physical activity
Administration Method: Subcutaneous injection pen
Common Side Effects: Nausea, vomiting, diarrhea, decreased appetite, abdominal discomfort
Interactions: Insulin or sulfonylureas may increase hypoglycemia risk; oral medicines may absorb differently with delayed gastric emptying; warfarin may need monitoring.
Medication may vary due to dosage and adminstration method
CAUTION: use caution with pancreatitis history and dehydration; monitor for suicidal ideation. Do not take if you have MEN 2, or if you or a family member have had thyroid cancer. Do not use in pregnancy.
Injection Training
Dosage: starting at 0.6 mg once daily.
Please note that this is a general guide and not an extended list of all information available on this medication. For specifics on injection training, or questions, please contact your provider.
Trulicity
tru-LISS-i-tee
Dulaglutide du-la-GLOO-tide
Uses: Type 2 diabetes management and selected cardiovascular risk reduction.
Administration Method: Subcutaneous injection pen
Common Side Effects: Nausea, diarrhea, vomiting, abdominal pain, decreased appetite
Interactions: Insulin or sulfonylureas may increase hypoglycemia risk; oral medicines may absorb differently with delayed gastric emptying; warfarin may need monitoring.
Medication may vary due to dosage and adminstration method
CAUTION: use caution with pancreatitis history and dehydration. Do not take if you have MEN 2, or if you or a family member have had thyroid cancer.
Injection Training
Dosage: starting at 0.75 mg daily; up to 4.5 mg maximum daily.
Please note that this is a general guide and not an extended list of all information available on this medication. For specifics on injection training, or questions, please contact your provider.
How to Use
Button
- Click on the buttons with your left mouse button to continue to the listed content
Qsymia
Mouse Over
- Hover your pointer arrow over the bolded text for further information
References
All Medication Information and pictures - Lexi-Drugs. UpToDate Lexidrug. UpToDate Inc. https://online.lexi.com https://www.drugs.com/drug-classes.html Videos: All videos are directly linked to the provider of said videos
Weight Center Prescription List - Bowie Campbell
Bowie
Created on March 31, 2026
Start designing with a free template
Discover more than 1500 professional designs like these:
View
Practical Microsite
View
Essential Microsite
View
Akihabara Microsite
View
Essential CV
View
Akihabara Resume
View
Momentum: Manager Guide
View
Momentum: First Operational Steps
Explore all templates
Transcript
2026 Prescription Guide
Dartmouth Health Weight Center
Enter
Click me for Instructions
Common Medications
Please click the name of the medication you would like to learn more about
Contrave
Wegovy
Qsymia
Saxenda
Zepbound
Trulicity
Metformin
Mounjaro
Ozempic
Victoza
If there is a medication you are currently prescribed by your provider, or are interested in taking that is not listed here, please get in touch with your Weight Center provider for more information
References
OZEMPIC
oh-ZEM-pick
Semaglutide sem-a-GLOO-tide
Uses: Type 2 diabetes management and certain cardiovascular or kidney-related uses
Administration Method: Subcutaneous injection
Common Side Effects: Nausea, vomiting, diarrhea, abdominal pain, and constipation
Interactions: Insulin or sulfonylureas may increase hypoglycemia risk; oral medicines may absorb differently with delayed gastric emptying; warfarin may need monitoring; caution with dehydration-producing medications
Medication may vary due to dosage and adminstration method
CAUTION: use caution with previous history of pancreatitis, diabetic retinopathy, gastroparesis, and procedures requiring anesthesia. Do not use if you have MEN 2 or if you or a family member have had thyroid cancer.
Injection Training
Dosage: 0.25 mg, 0.5 mg, 1 mg, 2 mg
Please note that this is a general guide and not an extended list of all information available on this medication. For specifics on injection training, or questions, please contact your provider.
Wegovy
we-GOH-vee
Semaglutide sem-a-GLOO-tide
Uses: Chronic weight management in eligible patients as part of reduced-calorie diet and increased physical activity
Administration Method: Subcutaneous injection , oral tablet
Common Side Effects: Nausea, vomiting, diarrhea, abdominal pain, and constipation
Interactions: Insulin or sulfonylureas may increase hypoglycemia risk; oral medicines may absorb differently with delayed gastric emptying; warfarin may need monitoring
CAUTION: Do not use if you have MEN 2 or if you or a family member have had thyroid cancer. report severe abdominal pain, vision changes, persistent vomiting, or thyroid tumor symptoms.
Medication may vary due to dosage and adminstration method
Injection Training
Dosage: 0.25 mg - 7.2 mg for auto injector; 1.25 mg, 4 mg, 9 mg, 25 mg oral tablet
Please note that this is a general guide and not an extended list of all information available on this medication. For specifics on injection training, or questions, please contact your provider.
Victoza
vik-TOE-za
Liraglutide Lir-a-GLOO-tide
Uses: Type 2 diabetes management and cardiovascular risk reduction in certain patients
Administration Method: Subcutaneous injection
Common Side Effects: Nausea, vomiting, diarrhea, decreased appetite, abdominal discomfort
Interactions: Insulin or sulfonylureas may increase hypoglycemia risk; oral medicines may absorb differently with delayed gastric emptying; warfarin may need monitoring.
Medication may vary due to dosage and adminstration method
CAUTION: use caution with pancreatitis history and dehydration. Do not take if you have MEN 2, or if you or a family member have had thyroid cancer.
Injection Training
Dosage: 0.6 mg, 1.2 mg, 1.8 mg
Please note that this is a general guide and not an extended list of all information available on this medication. For specifics on injection training, or questions, please contact your provider.
Zepbound
ZEP-bound
Tirzepatide tir-ZEP-a-tide
Uses: Chronic weight management and obstructive sleep apnea indication in eligible adults
Administration Method: Subcutaneous injection
Common Side Effects: Nausea, vomiting, diarrhea, constipation, abdominal pain
Interactions: Insulin or sulfonylureas may increase hypoglycemia risk; oral medicines may absorb differently with delayed gastric emptying; warfarin may need monitoring.
Medication may vary due to dosage and adminstration method
CAUTION: use caution with history of pancreatitis, dehydration, avoid use in pregnancy, monitor for mood changes. Do not take if you have MEN2, or if your or a family member have had thyroid cancer.
Pen Injection Training
Vial Injection Training
Dosage: 2.5 mg, 5 mg, 7.5 mg, 10 mg
Please note that this is a general guide and not an extended list of all information available on this medication. For specifics on injection training, or questions, please contact your provider.
Qsymia
kyoo-SIM-ee-uh
Phentermine and Topiramate
Uses: Chronic weight management in appropriate patients with obesity or overweight plus weight-related conditions
Administration Method: Oral extended-release capsule
Common Side Effects: Dry mouth, constipation, insomnia, tingling, dizziness
Interactions: MAO inhibitors; other stimulants; carbonic anhydrase inhibitors; CNS depressants; non-potassium-sparing diuretics
CAUTION: use caution with glaucoma, hyperthyroidism, and recent MAOI use; monitor heart rate, mood changes, and potassium. Do not take if you are pregnant or breast feeding.
Medication may vary due to dosage and adminstration method
Please note that this is a general guide and not an extended list of all information available on this medication. For specifics, or questions, please contact your provider.
Dosage: Specific dosages vary, starting dose is 3.75 mg Phentermine / 23 mg Topiramate once daily.
Metformin
met-FOR-min
Biguanide
Uses: Type 2 diabetes treatment; also widely used in related insulin-resistance settings
Administration Method: Oral tablet, extended-release tablet, oral solution
Common Side Effects: Diarrhea, nausea, abdominal upset, metallic taste
Interactions: Iodinated contrast exposure; alcohol excess; cationic drugs affecting renal clearance; carbonic anhydrase inhibitors; other glucose-lowering drugs may increase hypoglycemia when combined
Medication may vary due to dosage and adminstration method
CAUTION: Take with food to reduce stomach upset; report severe weakness, breathing trouble, or muscle pain; alert your provider of liver impairment. Do not take if you have severe renal dysfunction, or are at risk for lactic acidosis.
Please note that this is a general guide and not an extended list of all information available on this medication. For specifics, or questions, please contact your provider.
Dosage: 500 mg - 1000 mg
Contrave
CON-trayv
opioid antagonist plus aminoketone antidepressant
Uses: Chronic weight management in appropriate adults with obesity or overweight plus weight-related conditions
Administration Method: Oral extended-release tablet
Common Side Effects: Nausea, constipation, headache, dry mouth, insomnia
Interactions: Opioids; MAO inhibitors; other bupropion-containing products; alcohol misuse; medicines that lower seizure threshold
Medication may vary due to dosage and adminstration method
CAUTION: Contraindicated in seizure disorder, anorexia or bulimia, uncontrolled hypertension, chronic opioid use, abrupt withdrawal from alcohol or sedatives, and MAOI use; monitor for suicidality and blood pressure increases. Follow the titration schedule carefully; do not take extra tablets; avoid opioid pain medicines while using it
Please note that this is a general guide and not an extended list of all information available on this medication. For specifics, or questions, please contact your provider.
Dosage: Naltrexone 8mg / Bupropion 90 mg (Most Common)
Mounjaro
moun-JAR-oh
Tirzepatide tir-ZEP-a-tide
Uses: Type 2 diabetes management
Administration Method: Subcutaneous injection
Common Side Effects: Nausea, vomiting, diarrhea, constipation, abdominal pain
Interactions: Insulin or sulfonylureas may increase hypoglycemia risk; oral medicines may absorb differently with delayed gastric emptying; warfarin may need monitoring.
Medication may vary due to dosage and adminstration method
CAUTION: use caution with history of pancreatitis, dehydration, avoid use in pregnancy, monitor for mood changes. Do not take if you have MEN2, or if your or a family member have had thyroid cancer.
Pen Injection Training
Vial Injection Training
Dosage: 2.5 mg once weekly up to a maximum of 15 mg once weekly
Please note that this is a general guide and not an extended list of all information available on this medication. For specifics on injection training, or questions, please contact your provider.
Saxenda
sax-EN-da
Liraglutide Lir-a-GLOO-tide
Uses: Chronic weight management with reduced-calorie diet and increased physical activity
Administration Method: Subcutaneous injection pen
Common Side Effects: Nausea, vomiting, diarrhea, decreased appetite, abdominal discomfort
Interactions: Insulin or sulfonylureas may increase hypoglycemia risk; oral medicines may absorb differently with delayed gastric emptying; warfarin may need monitoring.
Medication may vary due to dosage and adminstration method
CAUTION: use caution with pancreatitis history and dehydration; monitor for suicidal ideation. Do not take if you have MEN 2, or if you or a family member have had thyroid cancer. Do not use in pregnancy.
Injection Training
Dosage: starting at 0.6 mg once daily.
Please note that this is a general guide and not an extended list of all information available on this medication. For specifics on injection training, or questions, please contact your provider.
Trulicity
tru-LISS-i-tee
Dulaglutide du-la-GLOO-tide
Uses: Type 2 diabetes management and selected cardiovascular risk reduction.
Administration Method: Subcutaneous injection pen
Common Side Effects: Nausea, diarrhea, vomiting, abdominal pain, decreased appetite
Interactions: Insulin or sulfonylureas may increase hypoglycemia risk; oral medicines may absorb differently with delayed gastric emptying; warfarin may need monitoring.
Medication may vary due to dosage and adminstration method
CAUTION: use caution with pancreatitis history and dehydration. Do not take if you have MEN 2, or if you or a family member have had thyroid cancer.
Injection Training
Dosage: starting at 0.75 mg daily; up to 4.5 mg maximum daily.
Please note that this is a general guide and not an extended list of all information available on this medication. For specifics on injection training, or questions, please contact your provider.
How to Use
Button
- Click on the buttons with your left mouse button to continue to the listed content
Qsymia
Mouse Over
- Hover your pointer arrow over the bolded text for further information
References
All Medication Information and pictures - Lexi-Drugs. UpToDate Lexidrug. UpToDate Inc. https://online.lexi.com https://www.drugs.com/drug-classes.html Videos: All videos are directly linked to the provider of said videos